Golukhova EZ, et al. - Since high residual platelet reactivity (HRPR) during dual antiplatelet therapy (DAPT) may impact clinical outcomes following percutaneous coronary interventions (PCI), researchers herein investigated if conventional clinical or laboratory indices at loading before stenting may serve as predictors of HRPR at 6 months of maintenance DAPT. In this work, only body mass index and soluble P-selectin were identified as independent predictors of future HRPR during maintenance-phase DAPT, though platelet reactivity before elective stenting was found to be related to numerous biomarkers.